Presentación R & D Day Event en New York :
Picar : PharmaMar
Picar : Melinda Telli, MD, Stanford University, Stanford School of Medicine, Stanford, CA
Picar : Martin Forster, MBBS MRCP PhD, UCL Cancer Institute, University College Hospital, London, UK
Picar : Sue Friedman, DVM, Executive Director of Facing Our Risks of Cancer Empowered (FORCE)
Melinda Telli, MD : “Development of lurbinectedin in BRCA2 mutation-associated BreastCancer” .
PM1183 Cancer de Mama , Resultados de clinica :
PM1183 , Resultados de Clinica del Tratamiento en un Paciente con C,ancer de Pulmón SCLC :
Sue Friedman : “Improve the Lives of Individuals & Families Affected by Hereditary Breast, Ovarian & Related Cancers” .